San Mateo, CA, United States of America

Michael J Postich


Average Co-Inventor Count = 8.4

ph-index = 3

Forward Citations = 44(Granted Patents)


Location History:

  • San Mateo, CA (US) (1998 - 2000)
  • Walnut Creek, CA (US) (2001 - 2003)

Company Filing History:


Years Active: 1998-2003

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Michael J Postich: Innovator in Neuraminidase Inhibitors

Introduction

Michael J Postich, based in San Mateo, California, has made significant contributions to the field of synthetic chemistry, particularly in the development of neuraminidase inhibitors. With a patent portfolio consisting of seven inventions, Postich stands out as an influential inventor in his field.

Latest Patents

Among his latest innovations is a patent for the "Preparation of cyclohexene carboxylate derivatives." This invention details new synthetic methods and compositions, specifically focusing on the preparation of intermediates that are essential for the synthesis of neuraminidase inhibitors. This patent not only outlines the new methods but also presents various formulas useful in the synthesis process, showcasing Postich's commitment to advancing chemical research.

Career Highlights

Michael J Postich is affiliated with Gilead Sciences, Inc., a prominent biopharmaceutical company dedicated to advancing innovative medicines. His work at Gilead is centered around the development of critical therapeutic agents, and his research contributions are making a notable impact on patient care.

Collaborations

Throughout his career, Postich has collaborated with accomplished colleagues such as Choung U Kim and Lawrence R McGee. These partnerships have allowed for a sharing of ideas and expertise, further driving innovation and progress within the pharmaceutical field.

Conclusion

Michael J Postich's inventive spirit and dedication to advancing synthetic methods are evident in his achievements and collaborations. His ongoing research continues to push the boundaries of chemistry and medicine, particularly in the realm of neuraminidase inhibitors, marking him as a key figure in the field of medicinal chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…